A detailed history of Boston Research & Management Inc transactions in Clorox CO stock. As of the latest transaction made, Boston Research & Management Inc holds 1,375 shares of CLX stock, worth $183,631. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,375
Holding current value
$183,631
% of portfolio
0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$139.73 - $157.03 $192,128 - $215,916
1,375 New
1,375 $210,000
Q1 2023

May 10, 2023

BUY
$139.79 - $158.24 $192,211 - $217,580
1,375 New
1,375 $217,000
Q1 2022

May 12, 2022

SELL
$127.62 - $186.6 $175,477 - $256,575
-1,375 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$129.53 - $152.47 $178,103 - $209,646
1,375 New
1,375 $206,000
Q2 2018

Jul 30, 2018

SELL
$114.8 - $135.25 $183,106 - $215,723
-1,595 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$129.33 - $139.04 $206,281 - $221,768
1,595
1,595 $210,000

Others Institutions Holding CLX

About CLOROX CO


  • Ticker CLX
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 123,356,000
  • Market Cap $16.5B
  • Description
  • The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-S...
More about CLX
Track This Portfolio

Track Boston Research & Management Inc Portfolio

Follow Boston Research & Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.